Zacks: Apollo Medical Holdings Inc (NASDAQ:AMEH) Receives Average Recommendation of “Buy” from Analysts

Share on StockTwits

Shares of Apollo Medical Holdings Inc (NASDAQ:AMEH) have earned a consensus broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation.

Brokerages have set a 12-month consensus price objective of $25.00 for the company and are anticipating that the company will post $0.13 EPS for the current quarter, according to Zacks. Zacks has also given Apollo Medical an industry rank of 62 out of 256 based on the ratings given to related companies.

Several analysts recently commented on AMEH shares. Zacks Investment Research lowered Apollo Medical from a “hold” rating to a “strong sell” rating in a report on Friday, August 9th. ValuEngine lowered Apollo Medical from a “buy” rating to a “hold” rating in a report on Tuesday, August 20th. Finally, TheStreet raised Apollo Medical from a “d” rating to a “c-” rating in a report on Friday, June 28th.

Apollo Medical stock traded down $0.10 during midday trading on Friday, hitting $20.67. 4,032 shares of the company were exchanged, compared to its average volume of 167,321. The firm has a market capitalization of $726.97 million, a PE ratio of 71.17, a price-to-earnings-growth ratio of 12.27 and a beta of -0.95. Apollo Medical has a fifty-two week low of $13.36 and a fifty-two week high of $23.32. The business has a fifty day simple moving average of $17.58 and a two-hundred day simple moving average of $17.74. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.14 and a current ratio of 2.14.

Apollo Medical (NASDAQ:AMEH) last posted its earnings results on Friday, August 9th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.05 by $0.04. The firm had revenue of $130.05 million for the quarter. Apollo Medical had a return on equity of 5.28% and a net margin of 1.94%. As a group, equities analysts expect that Apollo Medical will post 0.33 earnings per share for the current year.

In other news, insider Albert Waichow Young bought 5,000 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The shares were acquired at an average price of $15.01 per share, for a total transaction of $75,050.00. Following the completion of the transaction, the insider now directly owns 916,446 shares in the company, valued at approximately $13,755,854.46. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael F. Eng acquired 2,000 shares of Apollo Medical stock in a transaction that occurred on Thursday, September 12th. The shares were bought at an average price of $20.28 per share, for a total transaction of $40,560.00. In the last 90 days, insiders bought 31,200 shares of company stock worth $508,344. Company insiders own 11.83% of the company’s stock.

A number of large investors have recently bought and sold shares of AMEH. BlackRock Inc. grew its stake in shares of Apollo Medical by 98.7% in the second quarter. BlackRock Inc. now owns 728,124 shares of the company’s stock valued at $12,167,000 after buying an additional 361,766 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Apollo Medical by 9.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,164,827 shares of the company’s stock valued at $19,464,000 after purchasing an additional 102,267 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Apollo Medical by 52.4% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock valued at $332,000 after purchasing an additional 6,816 shares during the period. Wells Fargo & Company MN grew its stake in shares of Apollo Medical by 23.4% during the 2nd quarter. Wells Fargo & Company MN now owns 32,722 shares of the company’s stock valued at $547,000 after acquiring an additional 6,215 shares during the period. Finally, SG Americas Securities LLC bought a new position in shares of Apollo Medical during the 1st quarter valued at approximately $106,000. Institutional investors own 7.93% of the company’s stock.

About Apollo Medical

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Story: What are momentum indicators and what do they show?

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.